Contact FLARE

Flare Therapeutics
215 First Street, Suite 440
Cambridge, MA 02142

Office phone: 857-706-4400
General inquiries: contact@flaretx.com
FX-909 Trial: clinops@flaretx.com
Media inquiries: prusconi@vergescientific.com
Investors: julie.seidel@sternir.com

Compassionate Use Policy Statement:
Compassionate use, also called expanded access, refers to a pathway in which patients with serious or immediately life-threatening diseases may gain access to an investigational therapy outside the context of participation in clinical trials. At this time, Flare Therapeutics does not have an expanded access program that allows patients to have access to our investigational products prior to FDA approval.